Starboard's Smith targeting pharma firm for proxy fight By: CNBC.com News May 04, 2016 at 14:40 PM EDT Starboard Value is making a move against a pharmaceutical company it says is mismanaged, CEO Jeff Smith said Wednesday. Read More >> Related Stocks: Yahoo